Isolated Limb Perfusion With Tumor Necrosis Factor and Melphalan Prevents Amputation in Patients With Multiple Sarcomas in Arm or Leg
✍ Scribed by Dirk J. Grünhagen; Flavia Brunstein; Wilfried J. Graveland; Albertus N. van Geel; Johannes H. W. de Wilt; Alexander M. M. Eggermont
- Book ID
- 111771444
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 106 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: This retrospective study evaluated the benefit of using tumor necrosis factor (tnf) and melphalan administered via an isolated limb perfusion (ilp) in a series of patients with metastatic melanoma who failed initial ilp with chemotherapeutics. ## Methods: Seventeen patients with ex
## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using